Approximately 50 hospitals are currently evaluating the company's VIVO and LockeT devices, indicating a growing interest and potential market expansion. The acquisition of Cardionomics, Inc. and its ...

Jupiter Endovascular VP of Product Development Garrett Gomes discusses the Vertex system and proprietary Transforming ...

The company has initiated its CE Mark pivotal clinical trial for the QuickShot™ Nav large-area focal PFA Catheter and the ...

TruLeaf from the AllMeD Solutions group, successfully completed the first phase of a first-in-human clinical trial of a revolutionary system for tricuspid and mitral heart valve implantation via ...

Catheter Precision, Inc. has announced its first purchase order for the VIVO product from Sahlgrenska University Hospital in Sweden, which is the largest hospital in the country and has a substantial ...

Catheter Precision (VTAK) announced that the recent addition of key ablation procedures to ambulatory surgery centers, ASC, by Centers for ...

This is the first dedicated diagnostic catheter made available for Stereotaxis’ robotic technology, complementing robotic ablation catheter innovations. “Stereotaxis is rapidly evolving towards ...

ALISO VIEJO, Calif., April 20, 2022 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, ...

About VIVO Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, ...

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia recurrence after catheter ablation for atrial fibrillation (AF), results ...